PHARMA INFLUENCERS | NEWSLETTERS | WEBINARS

Tommaso Salanitri

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a new market/therapeutic area. A “Go-to-Market” strategy...

Field Medical Affairs In Pharma/Biotech: Effectiveness, Opportunities and Challenges

  Medical Affairs has risen very fast in the last years, becoming after an initial phase of “supporting function”, a highly crucial “leading function”, representing...

Medical Insights in Pharma Industry by Tommaso Salanitri

Gain an insight means obtain an accurate and deep understanding about some (complex) situation. Medical insights represent one of the most valuable information that Medical Affairs...

Business Analysis in Pharma Industry: from Market Research to Patient Journey. A Medical Affairs view

by Tommaso Salanitri, MD Business analysis in Pharma industry, either during the early phases of drug development phase or close to the launch, represents a...

Business Plan: a Medical Affairs perspective

A business plan is generally considered a process and specifically, a document, that summarizes the operational and financial objectives of a business - independently...

Recent Featured Articles

A Q&A Session with SpendEdge’s Thought Leader on the Current Pharmaceutical Industry Against the Backdrop of the Corona Virus Epidemic

LONDON--(BUSINESS WIRE)--SpendEdge, a leading procurement intelligence firm, has recently announced the completion of its latest Q&A article on the rising complexities and the ways...

Vifor Pharma acquires Priority Review Voucher

ST GALLEN, Switzerland--(BUSINESS WIRE)--Regulatory News: Vifor Pharma today announced that it has agreed to purchase a US Food and Drug Administration (FDA) priority review voucher...

Life Science Workforce Pipeline Sustainability Among Topics To Be Discussed at the MichBio BioTalent Summit

ANN ARBOR, Mich.--(BUSINESS WIRE)--MichBio, the Michigan Bioscience Industry Association, will hold a BioTalent Summit on March 16th focused on bringing together bio-industry stakeholders to...

Sensorion Receives Ethics Committee Approval to Include New Military Sites in SENS-401 Phase 2 study

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotech company which specializes in the development of novel therapies to restore, treat and...

Newron Expands Global Rett Syndrome Burden of Illness Survey Outreach to Europe and Australia

MILAN & MORRISTOWN, N.J.--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients...